10/13/2020Overview of China's Internet-Based Medicine

10/13/2020KBR: Medytox Suspected of Illegally Selling BTX in China

10/13/2020Rhizen Pharma and Curon Biopharma Enter License Deal for Tenalisib in ...

10/13/2020Immunotherapy Company 3D Medicines Raises Funds After Spin-Off

10/13/2020China: BMI Fund Cannot Afford to Cover Vaccinations

10/13/2020NMPA Issues the Announcement on Infrastructural Building for IT Tracin...

10/13/2020CDE Issues the Technical Guidelines for Clinical Evaluation of Radioac...

10/13/2020CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...

10/13/2020SAMR Solicits Comments on the Draft Guide to Antimonopoly in the Bulk ...

10/13/2020CRO PPD Opens New Clinical Research Lab in Suzhou

10/13/2020China Reviews Proposed Drug Patent Link Related Amendment to the Paten...

10/12/2020CDE Issues the Clinical Requirements for Drugs Marketed Outside China ...

10/12/2020Antengene Establishes New Drug Discovery Center in Shanghai

10/12/2020HitGen to Acquire Vernalis for $25M in Cash

10/12/2020China Sharpens Focus on Healthcare Cost Containment amid a Basket of M...

10/11/2020CStone Announces Completion of $200 million Share Sale to Pfizer

10/11/2020Antengene Announces Collaboration with WuXi Biologics to Advance the D...

10/11/20202020 Fall/Winter Promotion - Pharma China publications

10/10/2020Innovent and Lilly Announce the NMPA Approval of HALPRYZA® (Rituximab...

10/10/2020CDE Seeks Comments on Draft ICH Guideline E14-S7B

10/10/2020NHSA and MOF Issues Joint Notice to Advance the Trial for Inter-Provin...

10/9/2020Everest Medicines Launches IPO in Hong Kong

10/9/2020Corvus Pharma to Enter China through JV with Local Investor Group

10/9/2020Fosun's Hengenix to Initiate Trial of COVID-19 Antibody Drug in the U....

10/9/2020China Reduces VAT on A New Batch of Anticancer Drugs

10/9/2020Recent Executive Moves

10/9/2020NMPA Issues the Guide to Pharmaceutical Contract Manufacture Quality A...

10/9/2020WiCON Publishes the China Pharmaceutical Guide 2020 (15th Edition)

10/8/2020Boehringer Ingelheim Pledges Continued Direct Investments in China

10/8/2020Genor Completes $371 Million Hong Kong IPO; Market Cap Reaches $1.8B

Page:218/776 Total number of articles:23255: [First][<<] [216] [217] [218] [219] [220] [>>] [End]